Related Experiment Video
Updated: Jun 18, 2026

11:49
The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
Published on: August 16, 2014
In vivo angiogenesis and lymphangiogenesis models
L D Jensen1, R Cao, Y Cao
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, 171 77 Stockholm, Sweden.
Current Molecular Medicine
|November 21, 2009
Summary
This review analyzes common in vivo angiogenesis models, highlighting their limitations. Understanding these assay pitfalls is crucial for advancing angiogenesis research in disease diagnosis and drug discovery.
Area of Science:
- Biomedical Research
- Molecular Biology
- Vascular Biology
Background:
- Angiogenesis research is a rapidly expanding biomedical field with thousands of publications annually.
- The growth of this field necessitates robust and clinically relevant assay systems.
- Current assays are vital for disease diagnosis, prognosis, drug discovery, and mechanistic studies.
Purpose of the Study:
- To systematically analyze commonly used in vivo angiogenesis models.
- To identify and discuss the limitations and pitfalls of these assays.
- To provide valuable insights for improving current angiogenesis research methodologies.
Main Methods:
- Review and analysis of existing literature on angiogenesis assays.
- Focus on commonly employed in vivo models in species such as mice, chicks, and zebrafish.
- Systematic evaluation of assay reliability, stability, and clinical relevance.
Main Results:
- Identification of specific limitations and potential pitfalls in various in vivo angiogenesis assays.
- Comparison of the strengths and weaknesses of different model systems.
- Emphasis on the need for rigorous and validated assay development.
Conclusions:
- Awareness of assay limitations is critical for accurate interpretation of angiogenesis research findings.
- Improved assay design and validation can enhance the clinical relevance of angiogenesis studies.
- This review aims to guide researchers in selecting and utilizing appropriate angiogenesis models.
Related Concept Videos
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

